350 workers in Parsippany lose jobs at GlaxoSmithKline

PARSIPPANY — The consolidation of GlaxoSmithKline’s and Novartis’ consumer health care businesses have cut 350 jobs of GlaxoSmithKline at their Littleton Road and Kimball Road locations.

The jobs were cut last month, the notice said, as part of a consolidation of the two operations:

GlaxoSmithKline CEO Andrew Witty
GlaxoSmithKline CEO Andrew Witty

“In March 2015, GlaxoSmithKline and Novartis combined their consumer health care businesses into a joint venture,” the notice specifies. “The need to meet established financial and synergy targets and eliminate duplication is critical to the success of the joint venture and will necessitate a reduction in headcount at the Parsippany locations.”

Workers at two Parsippany facilities, 1500 Littleton Road and 200 Kimball Drive were affected. According to the WARN notice, workers were eligible for severance and benefits.

Affected positions include managers and employees in marketing and medical affairs, sales and operations, finance, information technology, consumer relations and regulatory affairs

WARN notices normally cover mass layoffs or facility closings as part of the Worker Adjustment and Retraining Notification Act of 1989.

Meanwhile, the company has been slashing jobs in other areas. Last year GSK announced plans to whittle down its Research Triangle Park, NC-based operations by 900 jobs–a decision affecting chemists, engineers, biologists, clinical development scientists, statisticians and others. And in March, the pharma giant said it would ratchet up that total, shedding 180 sales, managerial, operations, marketing and support staff roles–both in the field and in-house.

 

Comments

Comments